675毫克弗雷曼祖马布在2年内使用的有效性和持续性
Shohei Yoshida1, Noboru Imai2, Masato Keicho2
1Japanese Red Cross Society Shizuoka Hospital, Shizuoka, Japan. shohei1991mrk@yahoo.co.jp.
The journal of headache and pain
|March 12, 2025
概括
长期使用弗雷曼祖马布675毫克的季度剂量,显示了持续的有效性,减少了偶发性和慢性偏头痛患者的头痛频率. 一些患者取得了显著的改善,允许停止药物治疗.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 关于长期使用弗雷曼尼祖马布675毫克每季度剂量的有效性和坚持的现实数据有限.
- 这项研究评估了675毫克弗雷曼祖马布在情节性偏头痛 (EM) 和慢性偏头痛 (CM) 患者的2年疗效和坚持.
研究的目的:
- 为了评估 fremanezumab 675 mg 每季度剂量的长期疗效和患者坚持治疗.
- 在24个月的时间内,分析EM和CM患者停止治疗的原因.
主要方法:
- 单一中心的观察性研究,对年龄≥15岁的患者进行了季度一次675毫克的弗雷曼祖马布治疗.
- 头痛的频率和严重程度通过日记记录在24个月内.
- 从随访医疗记录中记录的停药原因.
主要成果:
- 27名患者完成了这项研究,70.4%的患者显示治疗有效性.
- 44.4%的患者继续服用675毫克的弗雷曼祖马布2年;25.9%的患者由于持续改善而停止服用.
- 缺乏有效性导致22.2%的患者停止治疗;其他原因包括注射部位红血和怀孕.
结论:
- 每季度服用675毫克的freemanezumab有效地减少了长期的头痛频率.
- 这种治疗可能使得在患有大量偏头痛恢复的患者中,可以停止药物治疗.
相关概念视频
Pharmacovigilance
764
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
764
Rational Dosage Regimen: Maintenance Dose and Loading Dose
3.8K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
3.8K
Dosage Regimen: Fixed Dose
1.8K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.8K
Antiepileptic Drugs: Potassium Channel Activators
140
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
140
